Can Psychedelics Actually Cure Depression and PTSD?
Is there about to be a psychedelic drug boom in mental health treatment? In May researchers released data from a phase 3 trial that used MDMA (street name: ecstasy) along with talk therapy to treat people who have post-traumatic stress disorder (PTSD). And COMPASS Pathways (NASDAQ: CMPS) is exploring the use of psilocybin (the active ingredient in "magic mushrooms") in combination with talk therapy, to treat people who have severe depression.
How big is this possible new market going to be? Corinne Cardina, bureau chief of healthcare and cannabis at Fool.com, and Motley Fool writer Taylor Carmichael discuss this emerging new treatment paradigm in a clip from Motley Fool Live, recorded on May 14.
Source Fool.com
